Bleeding disorders

Bleeding disorders 

Updated: 09/16/2020

© Jun Wang, MD, PhD

Hemostasis
  • Primary: Vasoconstriction, platelet activation
  • Secondary: Coagulation cascades
  • Results: Blood clot formation
Activation of platelets

Coagulation system
  • Intrinsic pathway: XII, XI, IX, VIII (8-12 except 10)
  • Extrinsic pathway: VII
  • Common pathway: X, V, prothrombin (II), fibrinogen (I) (4 smallest US dollar bills)
Etiology of bleeding disorders
  • Vascular dysfunction, including vitamin C deficiency, telangiectasia, allergic purpura, purpura associated with infections such as meningococcus and Rocky Mountain spotted fever, etc
  • Platelet disorders
Platelet dysfunctions associated with uremia, MDS, medications (NSAIDs etc) Bernard-Soulier syndrome, etc
    Coagulopathy
Other anticoagulants
  • Excessive fibrinolysis, including antiplasmin deficiency
Clinical presentations
  • Easy bleeding into skin, mucosa, body cavities
  • Presentations associated with organ/tissue dysfunction caused by bleeding
  • Chronic anemia
  • Primary hemostasis disorders: Single site, immediate bleeding after challenge, petechiae
  • Secondary hemostasis disorders: Multiple site, delayed bleeding after challenge, hematoma/hemarthrosis
Key laboratory approaches
  • Platelet count and function tests
  • Coagulation function tests
    • PT and INR (extrinsic pathway)
    • PTT (intrinsic pathway)
    • Coagulation factor test
    • Mild factor deficiencies will not cause prolonged PT or PTT
  • Mixing studies: If PT or PTT are normalized by mixture with normal plasma, factor deficiency is suggested, if not, presence of inhibitor is suggested


General considerations





Practice questions I
Practice questions II
 

Back to contents

Comments

Popular posts from this blog

Contents

Anemia

Lymphoid neoplasms